Supplemental regulatory filings are underway following positive results for remibrutinib in treating symptomatic dermographism. Topline results were announced from a phase 3 trial evaluating ...

William Truswell, MD, FACS, operates his own cosmetic and reconstructive facial surgery practice. Dr. Truswell was the first in his area in Western Massachusetts to have an accredited private office ...

For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...

In the 50-center international CURE study, diagnosis was delayed in 24.4% of the patients by at least a year. Pavel Kolkhir, MD, study lead and head of the chronic urticaria program in the Institute ...

During the winter, you may struggle to feel warm no matter how much you bundle up. But some people actually break out in hives when exposed to cold, whether they’re outdoors in the winter, walking ...

No advanced therapies approved to treat ColdU and SD—diseases of misery that dramatically impact all aspects of patient life Barzolvolimab is the only drug in development to demonstrate clinical ...

Chronic urticaria affects 17% of patients, with higher age, elevated BMI, and early prednisolone use as key determinants of prolonged disease duration. The study utilized data from the Julius General ...

Among patients with new-onset urticaria, 75% recovered within a week, whereas 17% progressed to chronic urticaria, and higher age at onset, elevated BMI, and early prednisolone use were associated ...

Mastocytosis is a rare disease characterized by proliferation and accumulation of mast cells in various organs. The maculopapular cutaneus mastocytosis is divided into three subtypes: papular/plaque ...